# Levinthal

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/levinthal

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Website: www.levinthal.bio
- Total disclosed funding: $1.6M
- Latest round: Angel (Jul 26, 2023)
- Investors on record: 4

## About

Based in Hangzhou, China and founded in 2021, Hangzhou Levinthal Biotechnology Co., Ltd., trading as Levinthal, is a biotech company that focuses on designing proteins. Haobo Wang, the founder and CEO of the company, studied under Sergey Ovchinnikov during his postdoctoral period at Harvard University, studying protein co-evolution and artificial intelligence. In March 2026, Levinthal raised a venture funding from Zhongshan Venture Capital.
The company's main product is the protein design platform Lésign®. The protein design platform Lésign® can embed biological phylogeny and physical potential energy information into the AI co-evolution analysis model to redesign and generate protein structures. Its products are used in the fields of environmental protection, food safety and medical treatment.
The company generates revenue by doing R&D, and providing a protein design platform and other related services.

## Funding rounds

- Angel, Jul 26, 2023 — Kaitai Capital, Panlin Capital, ZhenFund, Zhejiang Hongshi Private Equity Fund Management
- Seed, Feb 8, 2022, $1.6M — ZhenFund

## Investors

- ZhenFund (https://capitalatlas.ai/funds/zhenfund) — Seed, Angel
- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Angel
- Panlin Capital (https://capitalatlas.ai/funds/panlin-capital) — Angel
- Zhejiang Hongshi Private Equity Fund Management — Angel